Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients.
about
ADP-ribosylation factor 6 mediates E-cadherin recovery by chemical chaperonesHereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.sCNAphase: using haplotype resolved read depth to genotype somatic copy number alterations from low cellularity aneuploid tumors.Family history and the risk of gastric cancer.Genetic screening for familial gastric cancer.Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literatureE-cadherin destabilization accounts for the pathogenicity of missense mutations in hereditary diffuse gastric cancer.Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers.Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer.Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing.Helicobacter pylori bacteria alter the p53 stress response via ERK-HDM2 pathway.Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family RegistryGenetics, pathology, and clinics of familial gastric cancer.Hereditary diffuse gastric cancer: association with lobular breast cancer.Genetics of hereditary diffuse gastric cancer: progress and future challenges.Familial gastric cancer: detection of a hereditary cause helps to understand its etiology.Gastric cancer in individuals with Li-Fraumeni syndromeGermline CDH1 deletions in hereditary diffuse gastric cancer familiesActionable, pathogenic incidental findings in 1,000 participants' exomes.Absence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patients.A short guide to hereditary diffuse gastric cancer.Expression profile of E-cadherin, estrogen receptors, and P53 in early-onset gastric cancersPathology and genetics of familial gastric cancer.Hereditary gastric cancer.E-cadherin germline mutation carriers: clinical management and genetic implications.Hereditary cancer risk assessment: challenges for the next-gen sequencing era.Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future.Runx3 in Immunity, Inflammation and Cancer.Quantification of mutant E-cadherin using bioimaging analysis of in situ fluorescence microscopy. A new approach to CDH1 missense variants.Relevance of MET activation and genetic alterations of KRAS and E-cadherin for cetuximab sensitivity of gastric cancer cell lines.Quantification of topological features in cell meshes to explore E-cadherin dysfunction.Familial gastric cancers with Li-Fraumeni Syndrome: a case repast.CDH1/E-cadherin germline mutations in early-onset gastric cancer.The importance of E-cadherin binding partners to evaluate the pathogenicity of E-cadherin missense mutations associated to HDGC.A novel CDH1 germline missense mutation in a sporadic gastric cancer patient in north-east of Italy.Searching for E-cadherin gene mutations in early onset diffuse gastric cancer and hereditary diffuse gastric cancer in Korean patients.Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer.A new familial gastric cancer-related gene polymorphism: T1151A in the mismatch repair gene hMLH1.
P2860
Q28476496-1F9E7795-19E6-42A8-A3D4-C360FD540384Q30652890-8467B247-05C6-4812-8D03-7435435FF090Q33558237-5E53F0DB-FDE1-4FAC-9585-342C0561AB3DQ33630778-BF2B30B7-AB80-479C-B727-A327AD5CF7D7Q33732282-E1E0FFE4-FA14-40BF-B1B8-67041B8524FAQ34094855-200A1341-555F-4439-98FD-E04BBBDF8ADCQ34120710-F8EB84A9-46E3-4433-B56B-98BF0B3A0545Q34217518-871DAAF3-9E55-453A-8B5A-B86FDD18FC12Q34414768-6B4877FF-AD8D-4A1C-84B8-2A5455B9F071Q35034978-D2671EC7-37B4-488F-B468-9F9753157B2EQ35146870-0BCC1DF0-2A28-46DC-B365-6EE21D2B285BQ35176360-5F9A6754-500D-446E-AD0B-B9C600EEED21Q35735103-96AE17D3-C565-48F0-A0DB-F4ABEB062ABFQ36406529-32108E93-79E5-4450-ACC6-BAC04C3F2815Q36477282-B9A1B14E-B028-44C0-B328-12E27ACD248EQ36512515-21A08CB0-333D-466B-B499-CB30D84080C1Q36541982-95DC1532-8332-457A-8801-345655F5BA21Q36678769-EEDFFE36-ACF2-4A5A-B463-DBDA188B5CA5Q37154264-04C8A0B3-4A1B-4C69-9E80-DC8270B1D5FEQ37217044-F2B9C2BD-245B-4A43-80BB-0292836EE5D9Q37318009-96497A11-F71A-4BBA-B698-F0F6579A4B61Q37331082-6D83AACF-03B2-442B-A5BB-EDE82A764BF4Q37577919-6B8959E4-0585-4FC0-869D-A516E3C70AD2Q37756363-F1443BC6-FEE2-47CC-A081-7E3063D1E35AQ38050931-0B92B6B1-A0D1-468D-8A70-51A3C1B0FF8FQ38261630-565805EB-2197-4ADA-A951-4CDE0B297C2DQ38411228-02C1E7DE-BEEA-4DA6-94BE-34FC89A85180Q38826581-50832BD7-7395-4D46-8CD0-305D64CC4CA3Q38904246-A2283B59-5BDB-4455-9563-CEB5FFE46E01Q38941242-71CE910A-0C58-4494-BC60-2FDFCEEE9450Q39404068-76E42AF6-56B3-4B95-BDAF-1CAD794F41A6Q41085527-ED7FE787-468B-4D6C-AE1E-446422258E92Q42337388-CF523427-3CFA-4AA6-8CE6-16EE68C92149Q43146121-B7DE6A5E-DF28-4C90-AA9C-50BAAA0F1907Q43247035-197E3057-9F65-43E7-9BA0-9AED43E0DB7BQ43500841-2CF9B41A-D7DD-4CCC-BB54-EA34F3F804BEQ44283452-602D92DF-AC76-4A5B-9AA8-AEBC2A6B599EQ49219389-C4276547-6188-4004-AE75-BE1A5B1978BCQ54440242-3BCA8FFA-D2BD-41A2-A810-1BF9B3BB2FE2
P2860
Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Germline mutations of the E-ca ...... erman gastric cancer patients.
@ast
Germline mutations of the E-ca ...... erman gastric cancer patients.
@en
type
label
Germline mutations of the E-ca ...... erman gastric cancer patients.
@ast
Germline mutations of the E-ca ...... erman gastric cancer patients.
@en
prefLabel
Germline mutations of the E-ca ...... erman gastric cancer patients.
@ast
Germline mutations of the E-ca ...... erman gastric cancer patients.
@en
P2093
P356
P1476
Germline mutations of the E-ca ...... erman gastric cancer patients.
@en
P2093
Biedermann K
Holinski-Feder E
Huntsman D
Neutzling A
P356
10.1136/JMG.2003.015594
P407
P577
2004-06-01T00:00:00Z